Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01746082
Show Display Options
Rank Status Study
1 Completed Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
Condition: Influenza
Intervention: Biological: Influenza A/H3N2 variant Vaccine

Indicates status has not been verified in more than two years